Elan Corporation Plc (ELN) 13.01 0.15

Elan Corp. PLC ADS
(ELN) 13.01 0.15

Last Trade:	13.00	Day Range:	12.88 - 13.05
Trade Time:	11:02AM	52wk Range:	6.10 - 14.4025
Prev. Close:	12.85	Market Cap:	7.63B
Open:	13.05	Div Yield:	0
Volume:	1895259	PE:
EPS:	0.00

The Latest On ELN

UPDATE: Credit Suisse Downgrades Elan Corporation to Neutral 2/9/12 6:43am

Credit Suisse Downgrades Elan from Outperform to Neutral 2/9/12 6:00am

Benzinga's M&A Chatter for Thursday January 26, 2012 1/26/12 6:24pm

From Earlier: Biogen Idec and Elan Corporation Announce ASCEND Study to Evaluate the Effectiveness of TYSABRI as a Treatment for Secondary-Progressive Multiple Sclerosis 1/26/12 8:53am

Quest Diagnostics STRATIFY JCV First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients 1/20/12 4:00pm

Top Trade Ideas for the first trading day of the year 1/2/12 12:02pm

Stocks on Watch For Tomorrow 12/26/11 2:50pm

Stocks Watchlist For Tuesday, Dec 20 12/19/11 5:35pm

Benzinga's M&A Chatter for Monday December 19, 2011 12/19/11 4:40pm

Stocks On Watch For Next Week 12/17/11 1:46pm

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS 12/13/11 4:10am

Jefferies Maintains Buy on Elan, Remains Top Pick 12/12/11 8:40am

UPDATE: Credit Suisse Downgrades Elan Corporation to Neutral 2/9/12

Credit Suisse Downgrades Elan from Outperform to Neutral 2/9/12

Benzinga's M&A Chatter for Thursday January 26, 2012 1/26/12

From Earlier: Biogen Idec and Elan Corporation Announce ASCEND Study to Evaluate the Effectiveness of TYSABRI as a Treatment for Secondary-Progressive Multiple Sclerosis 1/26/12

Quest Diagnostics STRATIFY JCV First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients 1/20/12

Top Trade Ideas for the first trading day of the year 1/2/12

Stocks on Watch For Tomorrow 12/26/11

Stocks Watchlist For Tuesday, Dec 20 12/19/11

Benzinga's M&A Chatter for Monday December 19, 2011 12/19/11

Stocks On Watch For Next Week 12/17/11

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS 12/13/11

Jefferies Maintains Buy on Elan, Remains Top Pick 12/12/11

Benzinga's M&A Chatter for Thursday January 26, 2012 1/26/12

Top Trade Ideas for the first trading day of the year 1/2/12

Stocks on Watch For Tomorrow 12/26/11

Benzinga's M&A Chatter for Monday December 19, 2011 12/19/11

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS 12/13/11

Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar) 12/11/11

Biogen Idec Earnings Preview: Analysts Expect Higher EPS, Revenue 10/25/11

Stocks to Watch for 6/29/11: Fresh 52 Week Highs and Lows 6/29/11

Top 4 Stocks In The Drug Delivery Industry With The Highest Operating Margin 6/9/11

Trouble in Paradise? Five Stocks Near 52-Week Highs with Abnormally High Debt-to-Capital Ratios (CAR, CHTR, NLY, ELN, LBTYA) 4/19/11

Trading Moody's Downgrade of Irish Debt (RYAAY, ELN, EIRL, EPV) 4/15/11

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue (HSP, VRX, ELN, KV-A) 4/7/11

UPDATE: Credit Suisse Downgrades Elan Corporation to Neutral 2/9/12

Credit Suisse Downgrades Elan from Outperform to Neutral 2/9/12

Jefferies Maintains Buy on Elan, Remains Top Pick 12/12/11

Credit Suisse Upgrades Elan To Outperform 8/24/11

Jefferies Raises PT on Elan to $19 7/6/11

UPDATE: Hapoalim Raising Price Target On Alkermes (ALKS) 5/9/11

Trading Moody's Downgrade of Irish Debt (RYAAY, ELN, EIRL, EPV) 4/15/11

UBS Downs Elan To Neutral 4/12/11

RBC Capital Upgrades Elan Corporation To Outperform, $10 PT 4/7/11

Benzinga's Top Upgrades (CRM, SSS, ELN, ICE) 4/7/11

RBC Capital Ups ELN To Outperform 4/7/11

Jefferies Prime Time AM Tickers 1/25/11

Trade ELN
NOW!

Partner Headlines

Early Research Calls ( FII, AONE, MMM, BYD, CIT, JOY, ELN, CE, IRBT, DFT ) 2/9/12

The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company - Press Releases 2/6/12

Revenues Skyrocket at Merged Alkermes - Analyst Blog 2/3/12

New Study for Alkermes' Vivitrol - Analyst Blog 2/1/12

The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche - Press Releases 2/1/12

EPS Beat for Biogen; Outlook Weak - Analyst Blog 1/31/12

Biogen & Elan Announce Tysabri Trial - Analyst Blog 1/30/12

Earnings Preview: Biogen - Analyst Blog 1/30/12

Covidien, Other Irish Medical Names Behave Well 1/26/12

Positive News for Biogen & Elan - Analyst Blog 1/24/12

FDA Nod for Quest's STRATIFY JCV - Analyst Blog 1/23/12

The War Against Alzheimer's Requires Thinking Small (ASTX, AZN, PFE, ELN, ILNS) 1/3/12

Press Releases

Elan Reports Fourth Quarter and Full-Year 2011 Financial Results 2/8/12 Business Wire Story

Elan to Present at the Leerink Swann 2012 Global Healthcare Conference 2/1/12 Business Wire Story

ASCEND Study to Evaluate the Effectiveness of TYSABRI® (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis 1/27/12 Business Wire Story

Elan Announces Webcast of Fourth Quarter and Full-Year 2011 Financial Results 1/25/12 Business Wire Story

FDA Updates TYSABRI® (natalizumab) Label to Include Anti-JC Virus Antibody Status as a PML Risk Factor 1/20/12 Business Wire Story

Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients 1/20/12 Newswire Story

Rescentris CERF Electronic Lab Notebook (ELN) Software Fuels Multi-Site Collaboration for the National Alliance for Advanced Biofuels and Bioproducts (NAABB) 1/19/12 PRWeb Story

RBCC Enters New World of Opportunity 1/13/12 Business Wire Story

RBCC Showcases New Biotech Investment Model 1/3/12 Business Wire Story

Critical Alerts For McDonald's, Best Buy, Computer Sciences Corporation, American Eagle Outfitters, and Elan Released By Seven Summits Research 12/28/11 Newswire Story

RBCC to Join With Life Science Research Group BioHouston 12/13/11 Business Wire Story

University College Dublin and Elan Announce Initiative to Create Leadership in Biotechnology 12/12/11 Business Wire Story

Get the latest ELN stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Elan Corp. PLC ADS stock price.

Elan Corp. PLC ADS by YCharts

Elan Corporation Plc (ELN) 13.01 0.15

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On ELN

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social